To pill or not to pill in GnRH antagonist cycles: that is the question!
- PMID: 25447926
- DOI: 10.1016/j.rbmo.2014.09.010
To pill or not to pill in GnRH antagonist cycles: that is the question!
Abstract
Worldwide, gonadotrophin-releasing hormone (GnRH) antagonists are gaining ground, and the number of patients being treated for IVF with a GnRH antagonist is increasing. Cycle planning in GnRH antagonist IVF cycles has been a challenge. During the past 2 years, debate has been ongoing about the possible disadvantages of oral contraceptive pill (OCP) pre-treatment in GnRH antagonist IVF cycles. A recent meta-analysis clearly showed a significant decrease in ongoing pregnancy rates between patients who received OCP pre-treatment and those who did not. In this review, the published meta-analysis are is evaluated. It is argued that caution must be exercised in drawing conclusions too quckly on whether or not OCP pre-treatment might have a negative effect on outcome in GnRH antagonist IVF cycles.
Keywords: GnRH antagonist; OCP; estrogens; scheduling.
Copyright © 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Comment in
-
To pill or not to pill in GnRH antagonist cycles: what should be the appropriate wash-out period?Reprod Biomed Online. 2015 May;30(5):557. doi: 10.1016/j.rbmo.2015.02.001. Epub 2015 Feb 7. Reprod Biomed Online. 2015. PMID: 25754224 No abstract available.
-
To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!Reprod Biomed Online. 2015 Jul;31(1):6-8. doi: 10.1016/j.rbmo.2015.04.001. Epub 2015 Apr 9. Reprod Biomed Online. 2015. PMID: 25985996
-
To pill or not to pill in GnRH-antagonist cycles: still an open debate.Reprod Biomed Online. 2015 Sep;31(3):445. doi: 10.1016/j.rbmo.2015.05.011. Epub 2015 May 27. Reprod Biomed Online. 2015. PMID: 26184849 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous